Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;19(9):1468-1495.
doi: 10.2174/1570159X19666210712151556.

Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia

Affiliations
Review

Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia

Alex B Speers et al. Curr Neuropharmacol. 2021.

Abstract

Background: Withania somnifera (WS), also known as Ashwagandha, is commonly used in Ayurveda and other traditional medicine systems. WS has seen an increase in worldwide usage due to its reputation as an adaptogen. This popularity has elicited increased scientific study of its biological effects, including a potential application for neuropsychiatric and neurodegenerative disorders.

Objective: This review aims to provide a comprehensive summary of preclinical and clinical studies examining the neuropsychiatric effects of WS, specifically its application in stress, anxiety, depression, and insomnia.

Methods: Reports of human trials and animal studies of WS were collected primarily from the PubMed, Scopus, and Google Scholar databases.

Results: WS root and leaf extracts exhibited noteworthy anti-stress and anti-anxiety activity in animal and human studies. WS also improved symptoms of depression and insomnia, though fewer studies investigated these applications. WS may alleviate these conditions predominantly through modulation of the hypothalamic-pituitary-adrenal and sympathetic-adrenal-medullary axes, as well as through GABAergic and serotonergic pathways. While some studies link specific withanolide components to its neuropsychiatric benefits, there is evidence for the presence of additional, as yet unidentified, active compounds in WS.

Conclusion: While benefits were seen in the reviewed studies, significant variability in the WS extracts examined prevents a consensus on the optimum WS preparation or dosage for treating neuropsychiatric conditions. WS generally appears safe for human use; however, it will be important to investigate potential herb-drug interactions involving WS if used alongside pharmaceutical interventions. Further elucidation of active compounds of WS is also needed.

Keywords: Anxiety; Ashwagandha; Withania somnifera.; depression; insomnia; stress.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Selected WS compounds tested, or found in WS extracts tested, for effects related to neuropsychiatric disorders.
Fig. (2)
Fig. (2)
Potential mechanisms by which WS exerts positive benefits on stress, anxiety, depression, and insomnia. (A higher resolution / colour version of this figure is available in the electronic copy of the article).

Similar articles

Cited by

References

    1. Balasubramani S.P., Venkatasubramanian P., Kukkupuni S.K., Patwardhan B. Plant-based Rasayana drugs from Ayurveda. Chin. J. Integr. Med. 2011;17(2):88–94. doi: 10.1007/s11655-011-0659-5. - DOI - PubMed
    1. Panossian AG, Efferth T, Shikov AN, et al. 2021.
    1. Doshi G.M., Une H.D., Shanbhag P.P. Rasayans and non-rasayans herbs: Future immunodrug - Targets. Pharmacogn. Rev. 2013;7(14):92–96. doi: 10.4103/0973-7847.120506. - DOI - PMC - PubMed
    1. Dar N.J. MuzamilAhmad. Neurodegenerative diseases and Withania somnifera (L.): An update. J. Ethnopharmacol. 2020;256:112769. doi: 10.1016/j.jep.2020.112769. - DOI - PubMed
    1. Tandon N., Yadav S.S. Safety and clinical effectiveness of Withania somnifera (Linn.) Dunal root in human ailments. J. Ethnopharmacol. 2020;255:112768. doi: 10.1016/j.jep.2020.112768. - DOI - PubMed